{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:20:33Z","timestamp":1787847633555,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aims:<\/jats:title>\n                    <jats:p>Acute loss of smell or anosmia is a common and sometimes the only symptom observed in patients with coronavirus disease-2019 (COVID-19). The objective of the study was to determine the prevalence, time of onset, and duration of anosmia in patients with COVID-19 infection and the association of anosmia with other symptoms and eosinophil count.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>Two hundred patients with laboratory-confirmed COVID-19 infection, who were asymptomatic or mildly symptomatic were assessed for olfaction with a nonirritant odor. The presence of anosmia was recorded, and a questionnaire integrating the anosmia reporting tool was filled. Patients with anosmia\/hyposmia were followed telephonically at 7 and 14 days for resolution of anosmia and other symptoms. The presence of anosmia was correlated with eosinophil count.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 200 COVID-19 patients, 87% were symptomatic. More than half of the patients had fever (56%). Anosmia was observed in 30% of the patients and hyposmia in 4% of patients. In 41% of the patients, olfactory loss was reported before diagnosis. The mean duration of anosmia was 7.8 (\u00b1 5) days; 97% of patients recovered with a resolution of symptoms within 2 weeks. Ageusia was the most commonly and significantly associated symptom with anosmia (66%, n = 45) followed by sore throat (41%), and rhinorrhea (28%). The symptoms in both the sexes were comparable. Absolute eosinophil count of &lt;40\/\u03bcL was observed in 59 patients (29.5%) and an absolute eosinophil count of 0 in 17 patients (8.5%). Among the 68 anosmic patients, 36 (47%) patients had eosinopenia, which was statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Anosmia is an early and sometimes the only symptom in approximately one-third of the patients with COVID-19 infection. Eosinophil count should be checked in anosomic patient with suspicion of COVID-19 infection. Objective tools for olfactory and gustatory assessment should be brought into practice for early and prompt diagnosis to control the spread of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joacp.joacp_653_20","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T10:32:48Z","timestamp":1618050768000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["The incidence of anosmia in patients with laboratory-confirmed COVID 19 infection in India"],"prefix":"10.4103","volume":"37","author":[{"given":"Vinod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishkarsh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachidanand Jee","family":"Bharati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Vig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240828","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of Coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-9-20240828","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"R4-9-20240828","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R5-9-20240828","first-page":"Doc04","article-title":"Smell and taste disorders","volume":"10","author":"Hummel","year":"2011","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"key":"R6-9-20240828","first-page":"e7918","article-title":"Anosmia and ageusia as the only indicators of COVID-19","volume":"12","author":"Zhang","year":"2020","journal-title":"Cureus"},{"key":"R7-9-20240828","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3201\/eid2606.200299","article-title":"Co-infection with SARS-CoV-2 and influenza a virus in patient with pneumonia, China","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R9-9-20240828","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0194599820922992","article-title":"COVID-19 Anosmia reporting tool: Initial findings","volume":"163","author":"Kaye","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R10-9-20240828","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00134-011-2170-z","article-title":"Eosinopenia, an early marker of increase mortality in critically ill medical patients","volume":"37","author":"Abidi","year":"2011","journal-title":"Intensive care Med"},{"key":"R11-9-20240828","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cmi.2020.05.017","article-title":"Anosmia in COVID-19 patients","volume":"26","author":"Hornuss","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R12-9-20240828","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.medmal.2020.04.006","article-title":"Features of anosmia in COVID-19","volume":"50","author":"Klopfenstein","year":"2020","journal-title":"Med Mal Infect"},{"key":"R13-9-20240828","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/lary.28692","article-title":"Anosmia and ageusia: Common findings in COVID-19 patients","volume":"130","author":"Vaira","year":"2020","journal-title":"Laryngoscope"},{"key":"R14-9-20240828","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"R15-9-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019- new coronavirus epidemic: Evidence for virus evolution","volume":"92","author":"Benvenuto","year":"2020","journal-title":"J Med Virol"},{"key":"R16-9-20240828","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SAS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"key":"R17-9-20240828","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.3346\/jkms.2020.35.e174","article-title":"Prevalence and duration of acute loss of smell or taste in COVID-19 patients","volume":"35","author":"Lee","year":"2020","journal-title":"J Korean Med Sci"},{"key":"R18-9-20240828","first-page":"446","article-title":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran","volume":"34","author":"Bagheri","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"R19-9-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/194589240401800107","article-title":"Local and systemic administration of corticosteroids in the treatment of olfactory loss","volume":"18","author":"Heilmann","year":"2004","journal-title":"Am J Rhinol"},{"key":"R20-9-20240828","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/qjmed\/hcaa089","article-title":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series","volume":"113","author":"Qian","year":"2020","journal-title":"QJM"},{"key":"R21-9-20240828","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"R22-9-20240828","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jaip.2018.04.031","article-title":"Eosinophils: Friends or foes?","volume":"6","author":"Chusid","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R23-9-20240828","doi-asserted-by":"crossref","first-page":"100375","DOI":"10.1016\/j.eclinm.2020.100375","article-title":"Eosinopenia and elevated CRP facilitate triage of COVID- 19 patients in fever clinic: A retrospective case-control study","volume":"23","author":"Li","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R24-9-20240828","doi-asserted-by":"crossref","first-page":"100439","DOI":"10.1016\/j.eclinm.2020.100439","article-title":"Eosinopenia and COVID-19 patients: So specific?","volume":"24","author":"Andreozzi","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R25-9-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and Coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_653_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:25:25Z","timestamp":1787844325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_653_20"}},"subtitle":["An observational study"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/joacp.joacp_653_20","relation":{},"ISSN":["0970-9185"],"issn-type":[{"value":"0970-9185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}